Medifast Inc (MED) 31.97 $MED Medifast, Inc. Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medifast Inc (MED) 31.97 $MED

Medifast, Inc. Announces Quarterly Dividend
PR Newswire - Wed Jun 15, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has declared a $0.25 cash dividend to its stockholders. The quarterly cash dividend of $0.25 per share is payable on August 10, 2016 to stockholders of record as of the close of business on June 27, 2016.
MED: 31.97 (-0.86)

Medifast, Inc. to Participate in the 17th Annual B. Riley & Co. Investor Conference
PR Newswire - Wed May 11, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Timothy Robinson, Chief Financial Officer, will present at the 17th Annual B. Riley & Co. Investor Conference on Wednesday, May 25, 2016 in Hollywood, CA.
MED: 31.97 (-0.86)

5 DuPont-Tested Stocks that Promise Solid Returns
Zacks Equity Research - Zacks Investment Research - Fri May 06, 12:42PM CDT
Taking a step beyond the basic ROE and analyzing it at an advanced level could lead to better returns.
PM: 97.71 (-4.19), TJX: 74.66 (-2.22), MED: 31.97 (-0.86), NVR: 1,695.62 (-32.00)

Medifast posts 1Q profit
Automated Insights - Wed May 04, 4:39PM CDT
OWINGS MILLS, Md. (AP) _ Medifast Inc. (MED) on Wednesday reported first-quarter profit of $4.3 million.
MED: 31.97 (-0.86)

Medifast, Inc. Announces First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the first quarter ended March 31, 2016.
MED: 31.97 (-0.86)

McCormick Buys Botanical Food Company for $114M Cash
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:42AM CDT
McCormick & Co., Inc. (MKC) recently announced the acquisition of Australia-based Botanical Food Company, Pty Ltd, a privately held firm, for approximately 150 million Australian dollars ($114 million) in cash.
MKC: 101.57 (-0.83), MED: 31.97 (-0.86), SYY: 49.92 (-0.37), CPB: 62.40 (-0.24)

Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2016
PR Newswire - Thu Apr 14, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, will announce financial results for the first quarter ended March 31, 2016 on Wednesday, May 4, 2016, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Chairman and Chief Executive Officer, and Timothy Robinson, Chief Financial Officer.
MED: 31.97 (-0.86)

McCormick Withdraws Bid for Premier Foods; Shares Fall
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:50PM CDT
McCormick & Co., Inc. (MKC) recently announced that it has abandoned its plans to acquire UK-based Premier Foods, after completing its due diligence review of the food manufacturer. Shares of McCormick declined 2.2% on Apr 13.
MKC: 101.57 (-0.83), MED: 31.97 (-0.86), SYY: 49.92 (-0.37), CPB: 62.40 (-0.24)

Moving Average Crossover Alert: Medifast (MED)
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 8:24AM CDT
Medifast Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MED: 31.97 (-0.86)

Medifast® Sports Nutrition Product Line Announces New Partnerships
PR Newswire - Mon Apr 04, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today three new strategic partnerships for its sports nutrition product line, Dual Fuel(TM). To help launch the product line developed for athletes and active consumers, the company has signed sponsorship agreements with both the Colonial Athletic Association and the Atlantic Hockey Conference, which will distribute Dual Fuel(TM) bars and ready-to-drink shakes to student-athletes and fans onsite at conference tournaments. The company has also hired Play By Play Sports, a powerful sports marketing agency partner, to advance its distribution footprint among college and university programs.
MED: 31.97 (-0.86)

Medifast® Celebrates Nutrition Month with New Cookbook Featuring Flavorful, Nutritionally Balanced Recipes
PR Newswire - Mon Mar 21, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to celebrate March's Nutrition Month with the launch of a premier Medifast cookbook, Simply Well(TM): An Everyday, Healthy Cookbook ©. It is designed to spice up meals while offering customers healthy choices to keep them feeling full and satisfied.
MED: 31.97 (-0.86)

Why Sunrun, Medifast, and Zumiez Slumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Fri Mar 11, 6:27PM CST
Image: Sunrun. Stocks rallied on Friday, finishing a fourth consecutive week of gains as investors bought into the idea that further government stimulus measures from central banks in Europe and elsewhere in the world might be enough to jump-start...
ZUMZ: 14.65 (-0.21), MED: 31.97 (-0.86)

Medifast, Inc. Announces Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Thu Mar 10, 3:05PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2015.
MED: 31.97 (-0.86)

Medifast® Announces Latest Industry and Community Recognitions for Chairman & Chief Executive Officer Michael MacDonald
PR Newswire - Tue Feb 02, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that its Chairman & CEO Michael MacDonald was appointed to serve as Treasurer of the Direct Selling Association (DSA), a national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. A member of the DSA executive committee since 2014, MacDonald is also an active board member of the Direct Selling Education Foundation (DSEF), which offers consumer, education, ethics, and entrepreneurship initiatives that help demonstrate direct selling's important role in supporting communities and strengthening economies.
MED: 31.97 (-0.86)

Nutrisystem (NTRI) Adds 16 Items to Menu, Unveils New Diet
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 10:50AM CST
Nutrisystem Inc. (NTRI) has added 16 new items to its ready-to-go and fresh-frozen line of products.
MED: 31.97 (-0.86), NTRI: 23.98 (-0.32), WMT: 71.96 (-0.14), WTW: 12.34 (-1.16)

Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer Research® and Rutgers University® to Launch Dual Fuel(TM)
PR Newswire - Wed Jan 20, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today the launch of a sports nutrition product line, which will be marketed through partnerships with Rutgers University® and The V Foundation for Cancer Research®. The V Foundation, one of the nation's leading cancer research funding organizations, was started by famed college basketball coach and revered Rutgers' Alum, Jim Valvano.
MED: 31.97 (-0.86)

Upgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Jan 12, 8:04AM CST
Medifast (NYSE:MED) was upgraded from Neutral to Buy at Sidoti today. The stock closed yesterday at $29.40 on volume of 179,000 shares, above average daily volume of 106,000. Over the past year, Medifast has traded in a range of $26.14 to $33.86 and closed yesterday at $29.40, 12% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.
MED: 31.97 (-0.86)

Take Shape For Life® Kicks-Off New Year with Success Stories Featured in People Magazine's Annual Half Their Size Issue
PR Newswire - Mon Jan 11, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to announce that three weight loss successes in their Take Shape For Life direct selling division have been featured in the January 11, 2016 People Magazine's Half Their Size issue, available on newsstands now. This year, Take Shape For Life successes Heather Patterson (43), and husband and wife team, Steven (57) and Susan Smelser (55), shared their inspirational stories and credited their weight-loss transformations to Take Shape For Life. In the issue, they highlighted the organization's proven products and programs, their Health Coaches, and community of support which fosters Optimal Health.
MED: 31.97 (-0.86)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading